AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00984854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Juvidex
Description: Intradermal Juvidex, 100μl of 400mM (11.28mg/100μl) administered just prior to wounding and 200μl administered 24 h later
Study NCT00984854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Juvidex
Description: Intradermal Juvidex, 100μl of 600mM (16.93mg/100μl) administered just prior to wounding and 200μl administered 24 h later
Study NCT00984854 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intradermal Placebo (0.9% phosphate buffered saline, pH 7.0), 100μl administered just prior to wounding and 200μl administered 24 later
Study NCT00122174 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Stress Busting Program for family caregivers
Study NCT03071822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: PIGLETs
Study NCT03071822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ifosfamide
Description: PIGLETs
Study NCT03071822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine
Description: PIGLETs
Study NCT03071822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-asparaginase
Description: PIGLETs
Study NCT03071822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Description: PIGLETs
Study NCT03071822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexamethasone
Description: PIGLETs
Study NCT00248586 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard CBT (S-CBT)
Description: Standard CBT (S-CBT) is a skills-based training program delivered to patients in 10 weekly, 1-hour sessions.
Study NCT00248586 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Minimal contact CBT (MC-CBT)
Description: Minimal contact CBT (MC-CBT) covers the same range of procedures featured in S-CBT but relies extensively on self study materials.
Study NCT02764658 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulmonary recovery on the AECOPD
Description: The combination effect of negative pressure ventilation, limb muscle exercise training program and fibit monitor on acute exacerbation of AECOPD. To investigate the daily physical activity in routine care patients with after AECOPD and stable stage.
Study NCT02125799 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Accelerated HF-rTMS (Magstim Rapid 2 stimulator)
Description: Twice daily rTMS sessions involving 10 Hz in 75 trains of 4 seconds duration, with 26 seconds intertrain intervals (6,000 pulses per day) at 120% of the resting motor threshold.
Study NCT02764658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine care on the AECOPD
Description: To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in Routine care patients wtih AECOPD and stable stage.
Study NCT02764658 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine care on the AECOPD
Description: To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in Routine care patients wtih AECOPD and stable stage.
Study NCT02399137 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Study NCT02399137 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Study NCT02764658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine care on the stable COPD
Description: To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in Non-Pulmanary recovery patients wtih stable COPD.
Study NCT02764658 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine care on the stable COPD
Description: To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in Non-Pulmanary recovery patients wtih stable COPD.
Study NCT01923662 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IST-16 (16-Channel implanted stimulator-telemeter
Description: Surgical implantation of IST-16 stimulator and electrodes to stimulate paralyzed muscles. Subjects will receive exercise and physical therapy with the implanted device. Functional training and laboratory assessments of clinical and technical performance will be conducted.
Study NCT01322347 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Soluble Ferric Pyrophosphate (SFP)
Description: Patients to receive 11 micrograms (µg) of iron/ deciliter (dL) of dialysate during dialysis 3 or 4 times/week for up to 18 months.
Study NCT02116452 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Supplemented Formula
Description: 50:50 mixture of GOS/PDX formula will be administered
Study NCT03505203 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Soothe
Description: An intervention in which parents are given information on how to respond to their baby's cues related to sleeping and fussiness.
Study NCT03505203 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep Safe
Description: An intervention in which parents are given information on a safe sleep environment, as well as other strategies to keep baby safe.
Study NCT02694900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manually chest compressions
Description: Chest compressions performed manually without any device
Study NCT02315716 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Autologous Stem Cell Transplant (ASCT)
Description: Randomisation to melphalan conditioned autologous stem cell transplant
Study NCT02694900 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cardiopump
Description: Chest compressions performed with Cardiopump
Study NCT02694900 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LifeLine ARM
Description: Chest compressions performed using mechanical chest compressions system LifeLine ARM
Study NCT02105038 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinner knob
Study NCT02105038 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No Knob
Study NCT00606619 — intervention group
Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: Conventional feeding
Description: Procedure of Conventional feeding group: Patients are supplied water on day 3 after operation, liquid diet on day 4 and 5 and soft diet on 6 day.
Study NCT00606619 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early oral feeding
Description: Procedure of Early oral feeding group: Patients are supplied water on day 1 after operation, liquid diet on day 2 and soft diet on day 3 day.
Study NCT03019718 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GSA-Online plus
Description: A 12-week online writing intervention based on the Core Conflictual Relationship Theme Method (CCRT) with feedback provided by online therapists.
Study NCT01351961 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: blood sampling
Description: take a sample of blood, 46 ml
Study NCT01351961 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: brain MRI and TEP cerebral
Description: magnetic resonance imaging
Study NCT01351961 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Assessment of cognitive functions
Description: Folstein MMSE, Mac Nair scale, Depression (GDS) scale, The Benton Visual Retention Test, Test of verbal fluency, formal and categorical, Trail Making Test, Grober et Buschke scale (RL/RI-16), Apathy Robert scale, Praxis rating Scale .
Study NCT01351961 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Electrocardiogram and blood pressure
Description: Electrocardiogramm Blood pressure monitoring
Study NCT01351961 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Vascular explorations
Description: Pulse wave velocity, VWF, IMT
Study NCT02667483 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DS-5141b
Description: DS-5141b, Subcutaneous injection
Study NCT00422032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clofarabine
Description: Group A: 15 mg/m\^2 IV over 1 hour daily for 5 days~Group B: 30 mg/m\^2 IV over 1 hour daily for 5 days
Study NCT03283020 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RemifentanilMNTX
Description: Remifentanil infusion TCI 3 ng/ml, Methylnaltrexone injection 0.3 mg/kg
Study NCT03283020 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PlaceboMNTX
Description: Placebo (NaCl 0.9%) TCI infusion, Methylnaltrexone injection 0.3 mg/kg
Study NCT02812758 — intervention group
Intervention type: DEVICE
Intervention: transthoracic echocardiography
Description: recording of data on cardiac output measured non-invasively by transthoracic echocardiography, including the SVV
Study NCT00497536 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Aspart (IAsp)
Description: IAsp 100 U.~≈ bolus protocol: From 6 pm until 6 am~• 50 % of habitual 24 hour insulin need/24 hours = basal rate (per hour)~From 8 am until 6 pm~1 dose/h + 50 % s.c. (≈ bolus).
Study NCT00497536 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Aspart (IAsp).
Description: IAsp 100 U From 6 pm until 8 am~• 50 % of habitual 24 hour insulin need/24 hours = basal rate (per hour)~From 8 am until 6 pm 50 % increase of basal rate
Study NCT00497536 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Aspart (IAsp)
Description: IAsp 100 U From 6 pm until 8 am~• 50 % of habitual 24 hour insulin need/24 hours = basal rate (per hour)~From 8 am until 6 pm 50 % increase of basal rate
Study NCT01589081 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Nicotine
Description: Subjects will be given an IV challenge dose of nicotine or placebo in a constant volume of 2 mL on any study session day. The nicotine solutions (1.0 mg/70kg or 1.5 mg/70kg or 2.0 mg/70kg) will be administered over 1 min. This rate of drug delivery (2 mL over one minute) has been safe in our IRB-approved studies of nicotine. Most investigators have administered nicotine over 10 seconds without any adverse reactions. We concur with the IRB recommendation that the lower doses (1.0 mg/70kg; and 1.5 mg/70kg) will be administered first and the higher dose (2.0 mg/70kg) will be administered last.
Study NCT01589081 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Progesterone
Description: To stimulate the luteal phase of the menstrual cycle, Prometrium capsules containing 200 mg of micronized progesterone or placebo (lactose containing) capsules will be administered orally at 120 minutes before the injection of IV nicotine.
Study NCT00799968 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Urokinase
Description: UK,bolus 4 400 U/kg followed by intravenous 2 200 U/kg•h for 12 hours
Study NCT00799968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Urokinase
Description: UK,20 000U/kg continuously intravenous infusion for 2 hours
Study NCT02315716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Consolidation with 4 cycles of CarCyDex
Description: Randomisation to 4 further cycles of Carfilzomib, Cyclophosphamide and Dexamethasone for responding patients following 4 cycles of induction chemotherapy
Study NCT02316782 — intervention group
Intervention type: DEVICE
Intervention: Blinded IVUS assessment
Description: Only the angiogram is used for stent placement
Study NCT01760083 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Biolimus-eluting stent implantation
Description: Recanalization of chronic coronary artery occlusion and subsequent implantation of one or ore Biosensor stents
Study NCT02396836 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 6 step technique
Description: Hand decontamination with alcohol hand rub using the World Health Organizations 6 step technique
Study NCT02396836 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3 step technique
Description: Hand decontamination with alcohol hand rub using the 3 step technique
Study NCT02350309 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lemborexant 5 mg
Description: Lemborexant 5 mg tablet.
Study NCT02350309 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg
Description: Lemborexant 10 mg tablet.
Study NCT02350309 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lemborexant-matched placebo.
Description: Lemborexant-matched placebo tablet.
Study NCT02350309 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Flurazepam 30 mg
Description: Flurazepam 30 mg capsule.
Study NCT03033407 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tailored mobile coaching messages
Description: Intervention was adding tailored mobile coaching to current usual diabetes care. The participants received regular mobile messages via Switch app according to entered data, such as self-monitoring of blood glucose, blood pressure, exercise, dietary record, medication record, and body weight. Contents of messages were alert for the unused, weather, behavioral recommendation, education about diabetes, and individualized advices.
Study NCT03033407 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tailored mobile coaching messages
Description: Intervention was adding tailored mobile coaching to current usual diabetes care. The participants received regular mobile messages via Switch app according to entered data, such as self-monitoring of blood glucose, blood pressure, exercise, dietary record, medication record, and body weight. Contents of messages were alert for the unused, weather, behavioral recommendation, education about diabetes, and individualized advices.
Study NCT02316782 — intervention group
Intervention type: DEVICE
Intervention: Nonblinded IVUS
Description: Angiogram, Grayscale IVUS and VH IVUS used for stent placement pre and post intervention
Study NCT01650363 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture, homeopathy, osteopathy- and reflexology
Description: a combination of the above mentioned treatments
Study NCT01650363 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Homeopathic placebo medication
Description: 2-3 mm small spheric suger pils
Study NCT04027166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methadone
Description: Methadone will be administered before study procedures
Study NCT04027166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methadone
Description: Methadone will be delayed (4 hours) until the end of the procedures
Study NCT00531843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fondaparinux sodium
Description: fondaparinux 2.5mg SubQ daily for DVT prophylaxis to be started by treating physicians once deemed safe and to be discontinued once patient in discharged from the hospital or at discretion of treating physicians.
Study NCT04276493 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Zanidatamab
Description: Administered intravenously
Study NCT04276493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Administered intravenously
Study NCT04276493 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Administered intravenously
Study NCT04276493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Administered orally
Study NCT00531843 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: sequential compression devices
Description: Sequential compression devices at all times during the patient's hospital admission will be used in patients who have a contraindication to pharmacologic DVT prophylaxis. This is already the current standard of care.
Study NCT01322347 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Standard dialysate
Description: Patients to receive standard dialysate (no iron) during dialysis 3 or 4 times/week.
Study NCT04276493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Administered intravenously
Study NCT04300556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Farletuzumab ecteribulin
Description: Farletuzumab ecteribulin intravenous infusion.
Study NCT04300556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Prednisone administered orally.
Study NCT04300556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: Prednisolone administered orally.
Study NCT04300556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone administered orally.
Study NCT02766699 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EGFR(V)-EDV-Dox
Description: EGFR(V)-EDV-Dox using EnGeneIC EDV™ technology is a bacterially derived minicell which packages a toxic payload, Doxorubicin, into a 400 nm particle which targets specific cancer cells using bispecific antibodies (BsAb). BsAb-targeted, payload-packaged EDV nanocells only exit the leaky blood vessels associated with tumors and enter into the tumor microenvironment. The BsAb binds to the tumor cell-surface receptor, where the EDV is taken up, broken down within the cancer cell and releases the Doxorubicin. The residual EDVs that do not make it into the tumor microenvironment, are engulfed by cells of the immune system and since the EDVs are derived from bacteria, they carry potent immuno-stimulating components which appear to bypass the immuno-suppression caused by the tumor.
Study NCT03682471 — intervention group
Intervention type: DRUG
Intervention: Deoxycholic acid Injection
Description: Solution for subcutaneous injection.
Study NCT03682471 — intervention group
Intervention type: DRUG
Intervention: Placebo
Description: Placebo, 10 mM sodium phosphate, 0.9% \[w/v\] sodium chloride in water for subcutaneous injection.
Study NCT02399137 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-Paclitaxel
Study NCT02399137 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab-Paclitaxel
Study NCT00632554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisolone 0.5 mg/kg/day for three months
Description: period of treatment
Study NCT00632554 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prednisolone 0.5 mg/kg/day for six months
Description: period of therapy
Study NCT04915391 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Skin biopsy and blood sample for inflammation markers, RNA and proteins
Description: A skin biopsy will be performed at the baseline visit from which primary cell cultures of fibroblasts and keratinocytes will be obtained. Four to six weeks later a second biopsy on the scar will be performed and analyzed anatomically and pathologically. In addition, at the initial visit, blood samples will be drawn for analysis of inflammation markers, RNA and proteins.
Study NCT03023488 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: flexible ureteroscopy
Description: Flexible ureteroscopy is an endourological procedure performed for kidney stones. The flexible ureteroscope is a device used to reach the renal cavities through the natural urinary tract in a retrograde fashion. During the operation, irrigation fluid is used to expand the cavities to provide space for movement of the device and also to provide clear vision.
Study NCT03023488 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Doppler Ultrasound examination
Description: peak systolic velocities (PSV) and end diastolic velocities (EDV) of the arteries will be measured and then resistive index (RI) and pulsatility index (PI) will be calculated.
Study NCT03023488 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: laser lithotripsy
Description: The laser fiber extending into the cavities through the working channel of the ureteroscope is used to fragment the stones. Laser energy is generated by the laser machine and transmitted to the stones via the laser fiber.
Study NCT00184262 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ERP cognitive therapy
Description: 15 exposure and response prevention (ERP) sessions in 3 months with a cognitive therapy rationale
Study NCT00184262 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ERP behavioral therapy
Description: 15 exposure and response prevention (ERP) sessions in 3 months with a behavioral therapy rationale
Study NCT02244580 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MammaTyper™
Description: MammaTyper™ kit is a molecular in vitro diagnostic test for the quantitative detection of the ribonuclease acid (RNA) expression status of the genes for estrogen receptor (ESR1), progesterone receptor (PGR), human epidermal growth factor receptor 2 (HER2) and proliferation antigen KI 67.
Study NCT03175094 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Holistic Health Recovery Program for HIV+
Description: Holistic Health Recovery Program for HIV+ (HHRP+) is a CDC-recommended, evidence based behavioral (psychoeducational) group intervention focused on harm reduction principles. The investigators systematically adapted HHRP+ using findings from qualitative interviews with the target population of adult women living with and at-risk for HIV who are justice-involved (on probation, parole, or recently released from prison or jail).